Inducing Remission in Type 1 Diabetes With Alefacept

NCT00965458 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

49

Enrollment

NIH

Sponsor class

Stopped Manufacturer discontinued production of Amevive®: business decision.

Conditions

New-onset Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL: Alefacept
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]